Quest Diagnostics, Inc (DGX) Becoming More Attractive for Investors

Jaxson Clark

Quest Diagnostics, Inc’s recent filing unveils that its CEO and President Davis J. E. unloaded Company’s shares for reported $10.59 million on Nov 25 ’25. In the deal valued at $192.22 per share,55,093 shares were sold. As a result of this transaction, Davis J. E. now holds 120,480 shares worth roughly $22.14 million.

Then, Gregg Vicky B sold 1,250 shares, generating $239,700 in total proceeds. Upon selling the shares at $191.76, the Director now owns 17,037 shares.

Before that, Davis J. E. bought 55,093 shares. Quest Diagnostics, Inc shares valued at $10,589,762 were divested by the Officer at a price of $192.22 per share.

Robert W. Baird downgraded its Quest Diagnostics, Inc [DGX] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Citigroup also remained covering DGX and has decreased its forecast on March 04, 2025 with a “Neutral” recommendation from previously “Buy” rating. Leerink Partners revised its rating on January 06, 2025. It rated DGX as “an Outperform” which previously was an “a Market perform”.

Price Performance Review of DGX

On Monday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock fall -2.86% to $183.77. Over the last five days, the stock has lost -3.91%. Quest Diagnostics, Inc shares have risen nearly 13.25% since the year began. Nevertheless, the stocks have risen 21.81% over the past one year. While a 52-week high of $197.55 was reached on 10/21/25, a 52-week low of $148.70 was recorded on 01/16/25.

Levels Of Support And Resistance For DGX Stock

The 24-hour chart illustrates a support level at 181.83, which if violated will result in even more drops to 179.88. On the upside, there is a resistance level at 187.55. A further resistance level may holdings at 191.33.

How much short interest is there in Quest Diagnostics, Inc?

A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2025-11-14, growing by 0.34 million shares to a total of 4.29 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 3.95 million shares. There was a rise of 8.02%, which implies that there is a positive sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.